Piper Sandler maintains Privia Health Gr at Overweight, raises price target to $38 from $36

Privia (PRVA) raised its 2026 outlook, expecting 6,000 clinicians by year-end, 23.9% EBITDA growth, and $2.91B in practice collections. It will exit a Montana partnership and acquire American Choice Healthcare for $36M, impacting 2027 metrics. Q3 results showed 12.2% year-over-year provider growth and 21.9% EBITDA increase.

Privia Health Group (PRVA) aims for 23.9% adjusted EBITDA growth by 2026, according to its Q3 2026 earnings call. The company plans to acquire Cano ACO for $36M, with CEO Parth Mehrotra highlighting strong provider signings and visibility into future growth.

Privia Health reported 3Q 2026 revenue of $656.96M, up 13.2% YoY, and net income of $13.49M, up 96.6% YoY. Growth was driven by increased patient care and attributed lives, while shared savings declined due to timing. The company added 12.2% more providers and saw a 19.2% increase in attributed lives.

Privia Health Group (PRVA) reported Q3 EPS of $0.21, beating estimates by $0.12, with revenue at $656.96M, exceeding expectations. The company guided FY 2026 revenue to $2.50B-$2.55B, above consensus. PRVA's stock is down 0.22% over 3 months and 6.59% over 12 months. InvestingPro rates its financial health as 'great performance'.

Privia Health Group reported Q3 earnings per share of $0.21, missing estimates by $0.03, while revenue of $657M exceeded expectations by $46.38M. The company raised its full-year 2026 outlook for all key financial metrics and announced an acquisition to expand its value-based care footprint.

Privia Health Group Inc. (PRVA) reported Q3 earnings of $13.5M, or 10 cents per share, beating estimates of 9 cents. Revenue was $657M, exceeding forecasts of $599.6M. The company expects full-year revenue between $2.35B and $2.45B.